Why the study?
Do medications with anticholinergic activity increase the risk of cognitive impairment and mortality in the older population?
Do medications with anticholinergic activity increase the risk of cognitive impairment and mortality in the older population?
Medications with anticholinergic activity are associated with an increased cumulative risk of cognitive impairment and mortality in older adults.
Supports minimizing anticholinergic burden in older adults; leaves open causality and need for randomized confirmation.
The use of medications with anticholinergic activity increases the cumulative risk of cognitive impairment and mortality.
No takes yet. Share an insight, caveat, or question.
Fox et al. (2011) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: